JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
Southern Missouri Bancorp
SMBC
$792M
| $166K | ﹤0.01% |
6,812
-6,552
| -49% | -$152K |
2017 Q4
10 quarters
|
|
|
GOGL
4177
DELISTED
Golden Ocean Group
GOGL
| $165K | ﹤0.01% |
42,721
-644,348
| -94% | -$2.26M |
2018 Q2
8 quarters
|
|
4178
Lifecore Biomedical
LFCR
$247M
| $165K | ﹤0.01% |
20,739
+12,241
| +144% | +$126K |
2017 Q4
10 quarters
|
|
4179
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.87B
| $165K | ﹤0.01% |
3,070
-127
| -4% | -$6.33K |
2016 Q1
17 quarters
|
|
4180
Preformed Line Products
PLPC
$2.03B
| $165K | ﹤0.01% |
3,314
-2,916
| -47% | -$142K |
2017 Q4
10 quarters
|
|
4181
Direxion Daily Small Cap Bear 3x ETF
TZA
$223M
| $164K | ﹤0.01% |
96
+95
| +9,500% | +$259K |
2020 Q1
1 quarter
|
|
4182
iShares US Infrastructure ETF
IFRA
$3.98B
| $163K | ﹤0.01% |
+6,868
| New | +$154K |
2020 Q2
0 quarters
|
|
4183
Kiniksa Pharmaceuticals
KNSA
$5.95B
| $163K | ﹤0.01% |
6,415
-2,480
| -28% | -$51.8K |
2018 Q3
7 quarters
|
|
4184
Kimbell Royalty Partners
KRP
$1.49B
| $163K | ﹤0.01% |
19,000
| – | – |
2019 Q1
5 quarters
|
|
|
APLT
4185
DELISTED
Applied Therapeutics
APLT
| $162K | ﹤0.01% |
4,497
+1,868
| +71% | +$78.2K |
2019 Q3
3 quarters
|
|
|
FPI
4186
Farmland Partners
FPI
$486M
| $162K | ﹤0.01% |
23,726
-21,234
| -47% | -$139K |
2016 Q1
17 quarters
|
|
|
GNTY
4187
DELISTED
Guaranty Bancshares
GNTY
| $161K | ﹤0.01% |
6,833
-12,043
| -64% | -$272K |
2017 Q4
10 quarters
|
|
|
OPTN
4188
DELISTED
OptiNose
OPTN
| $161K | ﹤0.01% |
1,438
-194,711
| -99% | -$13.9M |
2017 Q4
10 quarters
|
|
|
SP
4189
DELISTED
SP Plus Corporation
SP
| $161K | ﹤0.01% |
7,781
-24,290
| -76% | -$501K |
2017 Q4
10 quarters
|
|
4190
Amneal Pharmaceuticals
AMRX
$7.09B
| $160K | ﹤0.01% |
33,582
-5,397
| -14% | -$22.2K |
2018 Q2
8 quarters
|
|
|
CRNX
4191
DELISTED
Crinetics Pharmaceuticals
CRNX
| $160K | ﹤0.01% |
9,135
+5,482
| +150% | +$93.5K |
2018 Q3
7 quarters
|
|
4192
iShares MSCI Qatar ETF
QAT
$56.4M
| $160K | ﹤0.01% |
10,000
| – | – |
2018 Q4
6 quarters
|
|
|
QADA
4193
DELISTED
QAD Inc.
QADA
| $160K | ﹤0.01% |
3,888
+126
| +3% | +$5.31K |
2015 Q4
18 quarters
|
|
|
NOA
4194
North American Construction
NOA
$330M
| $159K | ﹤0.01% |
25,458
+1,208
| +5% | +$6.81K |
2017 Q2
12 quarters
|
|
4195
Navigator Holdings
NVGS
$1.46B
| $159K | ﹤0.01% |
24,776
-16,968
| -41% | -$106K |
2018 Q1
9 quarters
|
|
4196
PennantPark Floating Rate Capital
PFLT
$673M
| $159K | ﹤0.01% |
18,951
-38,410
| -67% | -$282K |
2013 Q2
28 quarters
|
|
4197
United States Lime & Minerals
USLM
$3.18B
| $159K | ﹤0.01% |
9,455
-10,300
| -52% | -$161K |
2016 Q4
14 quarters
|
|
4198
Viking Therapeutics
VKTX
$3.68B
| $159K | ﹤0.01% |
22,052
+597
| +3% | +$3.96K |
2018 Q2
8 quarters
|
|
|
TECD
4199
PUT
DELISTED
Tech Data Corp
TECD
| $159K | ﹤0.01% |
+1,100
| New | +$152K |
2020 Q2
0 quarters
|
|
4200
Marcus Corp
MCS
$822M
| $158K | ﹤0.01% |
11,938
-60,373
| -83% | -$809K |
2016 Q1
17 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.